These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 25331811)
1. Australian regulator insists on greater transparency of industry payments to doctors. Coopes A BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811 [No Abstract] [Full Text] [Related]
2. Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations. Rosenbaum L N Engl J Med; 2015 May; 372(19):1860-4. PubMed ID: 25946288 [No Abstract] [Full Text] [Related]
3. Conflicts of Interest. Strandberg TE N Engl J Med; 2015 Aug; 373(8):779. PubMed ID: 26287865 [No Abstract] [Full Text] [Related]
5. Conflicts of Interest. Roper N N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287863 [No Abstract] [Full Text] [Related]
6. Conflicts of Interest. Abramson J; Redberg R N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287862 [No Abstract] [Full Text] [Related]
7. Conflicts of Interest. Rosenbaum L N Engl J Med; 2015 Aug; 373(8):779-80. PubMed ID: 26287861 [No Abstract] [Full Text] [Related]
8. No more free lunches: it is time to own up. Fitzpatrick C BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907499 [No Abstract] [Full Text] [Related]
9. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations? Van Way C; Bohigian G; Gale A; Powell M; Hagan JC Mo Med; 2011; 108(5):320-9. PubMed ID: 22073488 [No Abstract] [Full Text] [Related]
10. Doctors and drug companies: the beauty and the beast? Guömundsson S Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261 [No Abstract] [Full Text] [Related]
11. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry. Pratt IS; Hughes CL; Slevin TJ Med J Aust; 2010 Mar; 192(5):294. PubMed ID: 20301814 [No Abstract] [Full Text] [Related]
12. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry. Barnes RK Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549 [No Abstract] [Full Text] [Related]
13. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry. Mitchell PB Med J Aust; 2009 Sep; 191(5):273-5. PubMed ID: 19740050 [TBL] [Abstract][Full Text] [Related]
14. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry. Gough IR; Dickinson I; Maddern G; Grigg M; Hillis DJ Med J Aust; 2010 Mar; 192(5):293-4. PubMed ID: 20201768 [No Abstract] [Full Text] [Related]
15. No more free lunches: it is time we all grew up. Wessely S BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907497 [No Abstract] [Full Text] [Related]
16. For richer, for poorer, in sickness and in health: the entanglement of science and marketing. Smith GP Aust N Z J Psychiatry; 2012 Jun; 46(6):498-500. PubMed ID: 22679202 [No Abstract] [Full Text] [Related]
17. Doctors and drug companies. Blumenthal D N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823 [No Abstract] [Full Text] [Related]
18. [Is it pertinent to investigate the relations between physicians and the drug industry]. Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930 [TBL] [Abstract][Full Text] [Related]
19. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement. Moynihan R BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621 [TBL] [Abstract][Full Text] [Related]
20. [Clinical practice and pharmaceutical industry: an always difficult relationship]. Mastai R Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851 [No Abstract] [Full Text] [Related] [Next] [New Search]